2-[4-Bromo-5-cyclopropyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]propanoic acid
- $445 - $1325
- Product name: 2-[4-Bromo-5-cyclopropyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]propanoic acid
- CAS: 1006320-26-8
- MF: C10H10BrF3N2O2
- MW: 327.0978096
- EINECS:
- MDL Number:MFCD03419747
- Synonyms:2-[4-Bromo-5-cyclopropyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]propanoic acid;2-[4-Bromo-5-cyclopropyl-3-(trifluoromethyl)pyrazol-1-yl]propanoic acid;1H-Pyrazole-1-acetic acid, 4-bromo-5-cyclopropyl-α-methyl-3-(trifluoromethyl)-
3 prices
Selected condition:
Brand
- Apolloscientific
- Crysdot
Package
- 1g
- 5g
- 10g
- ManufacturerApolloscientific
- Product numberPC410375
- Product description2-[4-Bromo-5-cyclopropyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]propanoicacid
- Packaging1g
- Price$445
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11369013
- Product description2-(4-Bromo-5-cyclopropyl-3-(trifluoromethyl)-1H-pyrazol-1-yl)propanoicacid 97%
- Packaging10g
- Price$1325
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11369013
- Product description2-(4-Bromo-5-cyclopropyl-3-(trifluoromethyl)-1H-pyrazol-1-yl)propanoicacid 97%
- Packaging5g
- Price$787
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Apolloscientific | PC410375 | 2-[4-Bromo-5-cyclopropyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]propanoicacid | 1g | $445 | 2021-12-16 | Buy |
Crysdot | CD11369013 | 2-(4-Bromo-5-cyclopropyl-3-(trifluoromethyl)-1H-pyrazol-1-yl)propanoicacid 97% | 10g | $1325 | 2021-12-16 | Buy |
Crysdot | CD11369013 | 2-(4-Bromo-5-cyclopropyl-3-(trifluoromethyl)-1H-pyrazol-1-yl)propanoicacid 97% | 5g | $787 | 2021-12-16 | Buy |
Properties
Boiling point :359.5±42.0 °C(Predicted)
Density :1.89±0.1 g/cm3(Predicted)
pka :3.31±0.10(Predicted)
Density :1.89±0.1 g/cm3(Predicted)
pka :3.31±0.10(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|